These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 29482150)

  • 1. Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets.
    Janjua NZ; Islam N; Kuo M; Yu A; Wong S; Butt ZA; Gilbert M; Buxton J; Chapinal N; Samji H; Chong M; Alvarez M; Wong J; Tyndall MW; Krajden M;
    Int J Drug Policy; 2018 May; 55():31-39. PubMed ID: 29482150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of case-ascertainment algorithms using health administrative data to identify people who inject drugs in Ontario, Canada.
    Greenwald ZR; Werb D; Feld JJ; Austin PC; Fridman D; Bayoumi AM; Gomes T; Kendall CE; Lapointe-Shaw L; Scheim AI; Bartlett SR; Benchimol EI; Bouck Z; Boucher LM; Greenaway C; Janjua NZ; Leece P; Wong WWL; Sander B; Kwong JC
    J Clin Epidemiol; 2024 Jun; 170():111332. PubMed ID: 38522754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of ICD-based algorithms to estimate the prevalence of injection drug use among infective endocarditis hospitalizations in the absence of a reference standard.
    McGrew KM; Carabin H; Garwe T; Jafarzadeh SR; Williams MB; Zhao YD; Drevets DA
    Drug Alcohol Depend; 2020 Apr; 209():107906. PubMed ID: 32145659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada.
    Binka M; Butt ZA; Wong S; Chong M; Buxton JA; Chapinal N; Yu A; Alvarez M; Darvishian M; Wong J; McGowan G; Torban M; Gilbert M; Tyndall M; Krajden M; Janjua NZ
    World J Gastroenterol; 2018 Mar; 24(11):1216-1227. PubMed ID: 29568202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
    Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS
    Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
    Islam N; Krajden M; Shoveller J; Gustafson P; Gilbert M; Buxton JA; Wong J; Tyndall MW; Janjua NZ;
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):200-210. PubMed ID: 28404135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription opioid treatment for non-cancer pain and initiation of injection drug use: large retrospective cohort study.
    Wilton J; Abdia Y; Chong M; Karim ME; Wong S; MacInnes A; Balshaw R; Zhao B; Gomes T; Yu A; Alvarez M; Dart RC; Krajden M; Buxton JA; Janjua NZ; Purssell R
    BMJ; 2021 Nov; 375():e066965. PubMed ID: 34794949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants.
    Janjua NZ; Kuo M; Chong M; Yu A; Alvarez M; Cook D; Armour R; Aiken C; Li K; Mussavi Rizi SA; Woods R; Godfrey D; Wong J; Gilbert M; Tyndall MW; Krajden M
    PLoS One; 2016; 11(3):e0150176. PubMed ID: 26954020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British Columbia.
    Butt ZA; Shrestha N; Wong S; Kuo M; Gesink D; Gilbert M; Wong J; Yu A; Alvarez M; Samji H; Buxton JA; Johnston JC; Cook VJ; Roth D; Consolacion T; Murti M; Hottes TS; Ogilvie G; Balshaw R; Tyndall MW; Krajden M; Janjua NZ;
    PLoS One; 2017; 12(8):e0183609. PubMed ID: 28829824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis.
    Hines LA; Trickey A; Leung J; Larney S; Peacock A; Degenhardt L; Colledge S; Hickman M; Grebely J; Cunningham EB; Stone J; Dumchev K; Griffiths P; Vickerman P; Mattick RP; Lynskey M
    Lancet Glob Health; 2020 Jan; 8(1):e76-e91. PubMed ID: 31839143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia.
    Butler K; Day C; Dietze P; Bruno R; Alati R; Burns L
    J Subst Abuse Treat; 2015 Nov; 58():90-4. PubMed ID: 26117080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of an Algorithm to Identify Infective Endocarditis in People Who Inject Drugs.
    Ball LJ; Sherazi A; Laczko D; Gupta K; Koivu S; Weir MA; Mele T; Tirona R; McCormick JK; Silverman M
    Med Care; 2018 Oct; 56(10):e70-e75. PubMed ID: 29200131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syndemic profiles of people living with hepatitis C virus using population-level latent class analysis to optimize health services.
    Clementi E; Bartlett S; Otterstatter M; Buxton JA; Wong S; Yu A; Butt ZA; Wilton J; Pearce M; Jeong D; Binka M; Adu P; Alvarez M; Samji H; Abdia Y; Wong J; Krajden M; Janjua NZ;
    Int J Infect Dis; 2020 Nov; 100():27-33. PubMed ID: 32810594
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Mittal ML; Guise A; Rafful C; Gonzalez-Zuñiga P; Davidson P; Vashishtha D; Strathdee SA; Werb D
    Subst Use Misuse; 2019; 54(14):2338-2350. PubMed ID: 31389282
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors of injecting cessation among a cohort of people who inject drugs in Tijuana, Mexico.
    Horyniak D; Strathdee SA; West BS; Meacham M; Rangel G; Gaines TL
    Drug Alcohol Depend; 2018 Apr; 185():298-304. PubMed ID: 29482055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccine effectiveness by HIV status and history of injection drug use: a test-negative analysis.
    Puyat JH; Wilton J; Fowokan A; Janjua NZ; Wong J; Grennan T; Chambers C; Kroch A; Costiniuk CT; Cooper CL; Lauscher D; Strong M; Burchell AN; Anis A; Samji H;
    J Int AIDS Soc; 2023 Oct; 26(10):e26178. PubMed ID: 37885156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multimorbidity model for estimating health outcomes from the syndemic of injection drug use and associated infections in the United States.
    Chiosi JJ; Mueller PP; Chhatwal J; Ciaranello AL
    BMC Health Serv Res; 2023 Jul; 23(1):760. PubMed ID: 37461007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy.
    Janjua NZ; Darvishian M; Wong S; Yu A; Rossi C; Ramji A; Yoshida EM; Butt ZA; Samji H; Chong M; Chapinal N; Cook D; Alvarez M; Tyndall M; Krajden M;
    Hepatol Commun; 2019 Apr; 3(4):478-492. PubMed ID: 30976739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Missed Opportunities for Human Immunodeficiency Virus (HIV) Testing During Injection Drug Use-Related Healthcare Encounters Among a Cohort of Persons Who Inject Drugs With HIV Diagnosed During an Outbreak-Cincinnati/Northern Kentucky, 2017-2018.
    Furukawa NW; Blau EF; Reau Z; Carlson D; Raney ZD; Johnson TK; Deputy NP; Sami S; McClung RP; Neblett-Fanfair R; de Fijter S; Ingram T; Thoroughman D; Vogel S; Lyss SB
    Clin Infect Dis; 2021 Jun; 72(11):1961-1967. PubMed ID: 32748940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia.
    Handanagic S; Sevic S; Barbaric J; Dominkovic Z; Dakovic Rode O; Begovac J; Bozicevic I
    Drug Alcohol Depend; 2017 Feb; 171():132-139. PubMed ID: 28088084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.